Evidence map›Paper›PMID 33130196›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

COVID-19 in the least developed, fragile, and conflict-affected countries - How can the most vulnerable be protected?

Shahul H Ebrahim, Ernesto Gozzer, Yusuf Ahmed, Rubina Imtiaz, John Ditekemena, N M Mujeeb Rahman, Patricia Schlagenhauf, Saleh A Alqahtani, Ziad A Memish

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Refugees and Covid-19: Beyond Health Risks to Insecurity.Schweizerische Zeitschrift fur Politikwissenschaft = Revue suisse de science politique = Swiss political science review · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 7 countries.

Shahul H EbrahimUniversity of Sciences, Technique and Technology, Bamako, Mali. Electronic address: ebrahimsh2@gmail.com.
Ernesto GozzerUniversidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: ernesto.gozzer@upch.pe.
Yusuf AhmedUniversity Teaching Hospitals and Levy Mwanawasa Medical University, Lusaka, Zambia. Electronic address: yusufahmed03@hotmail.com.
Rubina ImtiazChildren Without Worms, Task Force for Global Health, Decatur, GA, USA. Electronic address: rimtiaz@taskforce.org.
John DitekemenaKinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, Congo; Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon. Electronic address: jditekemena@pedaids.com.
N M Mujeeb RahmanMES Medical College Hospital, Perinthalmanna, India. Electronic address: drnmmujeeb@mesams.com.
Patricia SchlagenhaufUniversity of Zürich Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Zürich, Switzerland. Electronic address: Patricia.Schlagenhauf@uzh.ch.
Saleh A AlqahtaniDepartment of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: Salqaht1@jhmi.edu.
Ziad A MemishResearch and Innovation Center, King Saud Medical City, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.
King Faisal Specialist Hospital & Research Centre · SAMinistry of Health · SAThe Task Force for Global Health · USUniversidad Peruana Cayetano Heredia · PEUniversité des Sciences, des Techniques et des Technologies de Bamako · MLUniversity of Kinshasa · CDUniversity of Zurich · CHUniversity Teaching Hospital · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relentless spread of coronavirus disease 2019 (COVID-19) and its penetration into the least developed, fragile, and conflict-affected countries (LDFCAC) is a certainty. Expansion of the pandemic will be expedited by factors such as an abundance of at-risk populations, inadequate COVID-19 mitigation efforts, sheer inability to comply with community mitigation strategies, and constrained national preparedness. This situation will reduce the benefits achieved through decades of disease control and health promotion measures, and the economic progress made during periods of global development. Without interventions, and as soon as international travel and trade resume, reservoirs of COVID-19 and other vaccine-preventable diseases in LDFCAC will continue 'feeding' developed countries with repeated infection seeds. Assuring LDFCAC equity in access to medical countermeasures, funds to mitigate the pandemic, and a paradigm change in the global development agenda, similar to the post-World War II Marshall Plan for Europe, are urgently needed. We argue for a paradigm change in strategy, including a new global pandemic financing mechanism for COVID-19 and other future pandemics. This approach should assist LDFCAC in gaining access to and membership of a global interdisciplinary pandemic taskforce to enable in-country plans to train, leverage, and maintain essential functioning and also to utilize and enhance surveillance and early detection capabilities. Such a task force will be able to build on and expand research into the management of pandemics, protect vulnerable populations through international laws/treaties, and reinforce and align the development agenda to prevent and mitigate future pandemics. Lifting LDFCAC from COVID-related failure will offer the global community the best economic dividends of the century.

Indexed as

SARS-CoV-2Advisory CommitteesCOVID-19Developing CountriesGlobal HealthHumansConflict-countriesCOVID-19

Identifiers

PMID33130196
PMCPMC7833301
OpenAlexW3097763118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.